EUVIMEDEUVIMED entdecken
Crossref

A RARE CLINICAL PRESENTATION OF LANGERHANS CELL HISTIOCYTOSIS IN AN INFANT

Anca-Cristina Draganescu, Anuta Bilasco, Roxana Matei, Diana-Maria Bancila, Ilinca Trosca, Doina-Anca Plesca

Excellence in Pediatrics Abstracts · 04.12.2025 · 17

DOI: 10.66584/eip2025-339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Excellence in Pediatrics Abstracts, online erschienen am 04.12.2025. Verfasst von Anca-Cristina Draganescu und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Langerhans cell histiocytosis (LCH) is a rare disease characterized by accumulation of clonal dendritic cells in various organs. It can occur at any age, with peak incidence between 1-4 years of age. The diagnosis of LCH is based on histological examination with immunophenotyping: identification of characteristic cells and the presence of markers CD1a and/or CD207 (Langerine) on the surface of the lesional cells. Molecular pathology is also required to monitor treatment response and disease activity ( BRAF V600E mutation, mutations in MAPK genes).

Method

We report the case of a 4-month-old male infant with a 2-day history of respiratory distress with minimal oxygen requirement, enlarged cervical lymph nodes, and a progressive purplish papule rash for over 3 months. Enlarged liver and spleen were also noted on clinical examination and his chest radiography showed increased diffuse alveolar-interstitial markings in the upper half of the lungs. His blood work showed hemolytic anemia, and mild leukocytosis and thrombocytosis.

Results

Clinical suspicion of Langerhans cell histiocytosis was raised, and a skin biopsy confirmed the diagnosis based on the presence of Langerin and CD1a markers. The infant was later evaluated and had multiple osteolytic lesions on CT and radio-graphic scans. He was started on vinblastin and prednisone with rapid clinical improvement. Clinical course of LCH varies from single-system disease, limited to one organ like the skin or bone, to a rapidly progressive multi-system disease involving the lymph nodes, liver, spleen, bone marrow, lungs and pituitary gland, making its clinical presentation highly variable and requiring a high index of suspicion to consider the diagnosis, especially when involvement of the lungs affects less than 15 % of children with LCH.

Conclusion

This case underlines the need for a multidisciplinary approach in diagnosing multi-system LCH in children and also the need to have a high index of clinical suspicion in order to begin adequate life-saving treatment.

Zitieren

APA

Draganescu, A., Bilasco, A., Matei, R., Bancila, D., Trosca, I., & Plesca, D. (2025). A RARE CLINICAL PRESENTATION OF LANGERHANS CELL HISTIOCYTOSIS IN AN INFANT. Excellence in Pediatrics Abstracts, 17. https://doi.org/10.66584/eip2025-339

Vancouver

Draganescu A, Bilasco A, Matei R, Bancila D, Trosca I, Plesca D. A RARE CLINICAL PRESENTATION OF LANGERHANS CELL HISTIOCYTOSIS IN AN INFANT. Excellence in Pediatrics Abstracts. 2025;17. doi:10.66584/eip2025-339

BibTeX
@article{Draganescu2025,
  author = {Draganescu, Anca-Cristina and Bilasco, Anuta and Matei, Roxana and Bancila, Diana-Maria and Trosca, Ilinca and Plesca, Doina-Anca},
  title = {A RARE CLINICAL PRESENTATION OF LANGERHANS CELL HISTIOCYTOSIS IN AN INFANT},
  journal = {Excellence in Pediatrics Abstracts},
  year = {2025},
  volume = {17},
  doi = {10.66584/eip2025-339}
}
Kostenlos starten →